Astex Pharmaceuticals, Inc. - Strategy and SWOT Report
Astex Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Astex Pharmaceuticals, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Astex Pharmaceuticals, Inc. in the form of a SWOT analysis
An in-depth view of the business model of Astex Pharmaceuticals, Inc. including a breakdown and examination of key business segments
Intelligence on Astex Pharmaceuticals, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Astex Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Astex Pharmaceuticals, Inc. (Astex or 'the company'), a subsidiary of Otsuka America, Inc., is engaged in the discovery, development and commercialization of cancer therapies in the US. The company is headquartered in Dublin, California. In 2013, Otsuka Pharmaceutical, a wholly-owned subsidiary of Otsuka Holdings, completed the acquisition of Astex. Astex has not disclosed its financial details including revenue, and operating and net profits.
Reasons to Purchase:
Gain understanding of Astex Pharmaceuticals, Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Astex Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Astex Pharmaceuticals, Inc.’s business structure, strategy and prospects